![Anat Shirvan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anat Shirvan
Career history of Anat Shirvan
Former positions of Anat Shirvan
Companies | Position | Start | End |
---|---|---|---|
Atox Bio Ltd.
![]() Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 2009-12-31 | - |
APOSENSE LTD | Director/Board Member | 1996-10-08 | - |
Chief Tech/Sci/R&D Officer | 1997-11-30 | - | |
Founder | 2009-07-20 | - |
Training of Anat Shirvan
The Hebrew University of Jerusalem | Doctorate Degree |
Statistics
International
Israel | 4 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Aposense Ltd.
![]() Aposense Ltd. Pharmaceuticals: MajorHealth Technology Aposense Ltd. engages in the provision of proprietary conjugates. It offers platform technology which comprises the rational design of small molecular moieties with the increased affinity to the cell membranes imparting the conjugates compound with improved drug properties such as extended life span oral bioavailabity and selective at target site. The company was founded by Ilan Ziv and Jacob Gottenstein on October 9, 1996 and is headquartered in Petach-Tikva, Israel. | Health Technology |
Atox Bio Ltd.
![]() Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
- Stock Market
- Insiders
- Anat Shirvan
- Experience